CRISIL Limited Approves Q3 2025 Results and Declares Rs. 16 Third Interim Dividend
CRISIL Limited's Board approved Q3 and nine-month financial results for the period ending September 30, 2025. The company declared a third interim dividend of Rs. 16 per equity share, payable on November 6, 2025. The board meeting, held on October 17, 2025, lasted from 3:45 p.m. to 5:05 p.m. IST. Walker Chandiok & Co LLP conducted a limited review of the financial results.

*this image is generated using AI for illustrative purposes only.
CRISIL Limited , a leading analytics and risk solutions provider, has announced its financial results for the third quarter and nine months ended September 30, 2025, along with a significant dividend declaration. The company's Board of Directors convened on October 17, 2025, to approve these important financial matters.
Financial Results Approval
The Board of Directors has given its approval to the unaudited standalone and consolidated financial results for Q3 2025 and the nine-month period ending September 30, 2025. While specific financial figures were not disclosed in the available information, the approval of these results indicates that the company has completed its financial review for the period.
Dividend Declaration
In a move that may interest shareholders, CRISIL's Board has declared a third interim dividend for the financial year ending December 31, 2025. The details of the dividend are as follows:
| Dividend Details | Value |
|---|---|
| Dividend Amount | Rs. 16.00 per equity share |
| Face Value of Share | Re. 1.00 |
| Payment Date | November 6, 2025 |
This dividend declaration demonstrates the company's commitment to returning value to its shareholders.
Board Meeting Details
The crucial board meeting where these decisions were made took place on October 17, 2025. Here's a brief overview of the meeting:
| Meeting Aspect | Details |
|---|---|
| Commencement Time | 3:45 p.m. IST |
| Conclusion Time | 5:05 p.m. IST |
| Key Decisions | Approval of Q3 results and dividend declaration |
Audit Review
Walker Chandiok & Co LLP conducted a limited review of both the standalone and consolidated quarterly financial results. This review is in line with regulatory requirements and adds credibility to the financial statements presented by CRISIL Limited.
Investor Implications
The approval of the financial results and the declaration of a substantial interim dividend may be seen as positive signals by the investor community. However, investors are advised to consider these developments in the context of broader market conditions and the company's long-term performance before making any investment decisions.
CRISIL Limited continues to fulfill its obligations under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by promptly disclosing these material developments to the stock exchanges.
Historical Stock Returns for CRISIL
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.60% | -0.32% | -7.35% | -16.50% | -17.56% | +128.19% |








































